| HOME >> BIOLOGY >> TECHNOLOGY |
Common stock 113,013 109,031
Retained earnings (accumulated deficit) 3,106 (2,967)
Accumulated other comprehensive loss (393) (1,415)
Total shareholders' equity 115,726 104,649
Total liabilities and shareholders' equity $132,057 $120,903
Non-GAAP Operating Income Per Share
(In thousands, except per share data)
Three Months Ended Six Months Ended
September 30, September 30,
2008 2007 2008 2007
Shares used in the calculation of
operating income per share (non-
GAAP):
Weighted average common shares
outstanding - basic 21,779 21,448 21,757 21,380
Weighted average common shares
outstanding - diluted 22,304 22,110 22,363 22,103
Non-GAAP operating income per share -
basic $0.22 $0.19 $0.41 $0.40
Non-GAAP operating income per share -
diluted $0.22 $0.19 $0.39 $0.39
Revenues by Geographic Region
(In thousands)
Three Months Ended Six Months Ended
September 30, September 30,
2008 2007 2008 2007
North America $22,482 $21,071 $42,777 $40,240
International 5,206 4,121 9,483 7,883
Total revenues $27,688 $25,192 $52,260 $48,123
Revenues by Customer Group
(In thousands)
Three Months Ended Six Months Ended
'/>"/>
| SOURCE Abaxis, Inc. Copyright©2008 PR Newswire. All rights reserved |